Cargando…

An alternative conformation of ERβ bound to estradiol reveals H12 in a stable antagonist position

The natural ligand 17β-estradiol (E2) is so far believed to induce a unique agonist-bound active conformation in the ligand binding domain (LBD) of the estrogen receptors (ERs). Both subtypes, ERα and ERβ, are transcriptionally activated in the presence of E2 with ERβ being somewhat less active than...

Descripción completa

Detalles Bibliográficos
Autores principales: Souza, Paulo C. T., Textor, Larissa C., Melo, Denise C., Nascimento, Alessandro S., Skaf, Munir S., Polikarpov, Igor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471280/
https://www.ncbi.nlm.nih.gov/pubmed/28615710
http://dx.doi.org/10.1038/s41598-017-03774-x
_version_ 1783243917850836992
author Souza, Paulo C. T.
Textor, Larissa C.
Melo, Denise C.
Nascimento, Alessandro S.
Skaf, Munir S.
Polikarpov, Igor
author_facet Souza, Paulo C. T.
Textor, Larissa C.
Melo, Denise C.
Nascimento, Alessandro S.
Skaf, Munir S.
Polikarpov, Igor
author_sort Souza, Paulo C. T.
collection PubMed
description The natural ligand 17β-estradiol (E2) is so far believed to induce a unique agonist-bound active conformation in the ligand binding domain (LBD) of the estrogen receptors (ERs). Both subtypes, ERα and ERβ, are transcriptionally activated in the presence of E2 with ERβ being somewhat less active than ERα under similar conditions. The molecular bases for this intriguing behavior are mainly attributed to subtype differences in the amino-terminal domain of these receptors. However, structural details that confer differences in the molecular response of ER LBDs to E2 still remain elusive. In this study, we present a new crystallographic structure of the ERβ LBD bound to E2 in which H12 assumes an alternative conformation that resembles antagonist ERs structures. Structural observations and molecular dynamics simulations jointly provide evidence that alternative ERβ H12 position could correspond to a stable conformation of the receptor under physiological pH conditions. Our findings shed light on the unexpected role of LBD in the lower functional response of ERβ subtype.
format Online
Article
Text
id pubmed-5471280
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-54712802017-06-19 An alternative conformation of ERβ bound to estradiol reveals H12 in a stable antagonist position Souza, Paulo C. T. Textor, Larissa C. Melo, Denise C. Nascimento, Alessandro S. Skaf, Munir S. Polikarpov, Igor Sci Rep Article The natural ligand 17β-estradiol (E2) is so far believed to induce a unique agonist-bound active conformation in the ligand binding domain (LBD) of the estrogen receptors (ERs). Both subtypes, ERα and ERβ, are transcriptionally activated in the presence of E2 with ERβ being somewhat less active than ERα under similar conditions. The molecular bases for this intriguing behavior are mainly attributed to subtype differences in the amino-terminal domain of these receptors. However, structural details that confer differences in the molecular response of ER LBDs to E2 still remain elusive. In this study, we present a new crystallographic structure of the ERβ LBD bound to E2 in which H12 assumes an alternative conformation that resembles antagonist ERs structures. Structural observations and molecular dynamics simulations jointly provide evidence that alternative ERβ H12 position could correspond to a stable conformation of the receptor under physiological pH conditions. Our findings shed light on the unexpected role of LBD in the lower functional response of ERβ subtype. Nature Publishing Group UK 2017-06-14 /pmc/articles/PMC5471280/ /pubmed/28615710 http://dx.doi.org/10.1038/s41598-017-03774-x Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Souza, Paulo C. T.
Textor, Larissa C.
Melo, Denise C.
Nascimento, Alessandro S.
Skaf, Munir S.
Polikarpov, Igor
An alternative conformation of ERβ bound to estradiol reveals H12 in a stable antagonist position
title An alternative conformation of ERβ bound to estradiol reveals H12 in a stable antagonist position
title_full An alternative conformation of ERβ bound to estradiol reveals H12 in a stable antagonist position
title_fullStr An alternative conformation of ERβ bound to estradiol reveals H12 in a stable antagonist position
title_full_unstemmed An alternative conformation of ERβ bound to estradiol reveals H12 in a stable antagonist position
title_short An alternative conformation of ERβ bound to estradiol reveals H12 in a stable antagonist position
title_sort alternative conformation of erβ bound to estradiol reveals h12 in a stable antagonist position
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471280/
https://www.ncbi.nlm.nih.gov/pubmed/28615710
http://dx.doi.org/10.1038/s41598-017-03774-x
work_keys_str_mv AT souzapauloct analternativeconformationoferbboundtoestradiolrevealsh12inastableantagonistposition
AT textorlarissac analternativeconformationoferbboundtoestradiolrevealsh12inastableantagonistposition
AT melodenisec analternativeconformationoferbboundtoestradiolrevealsh12inastableantagonistposition
AT nascimentoalessandros analternativeconformationoferbboundtoestradiolrevealsh12inastableantagonistposition
AT skafmunirs analternativeconformationoferbboundtoestradiolrevealsh12inastableantagonistposition
AT polikarpovigor analternativeconformationoferbboundtoestradiolrevealsh12inastableantagonistposition
AT souzapauloct alternativeconformationoferbboundtoestradiolrevealsh12inastableantagonistposition
AT textorlarissac alternativeconformationoferbboundtoestradiolrevealsh12inastableantagonistposition
AT melodenisec alternativeconformationoferbboundtoestradiolrevealsh12inastableantagonistposition
AT nascimentoalessandros alternativeconformationoferbboundtoestradiolrevealsh12inastableantagonistposition
AT skafmunirs alternativeconformationoferbboundtoestradiolrevealsh12inastableantagonistposition
AT polikarpovigor alternativeconformationoferbboundtoestradiolrevealsh12inastableantagonistposition